Trademark: 88790882
Status Date
Monday, January 17, 2022
Filing Date
Monday, February 10, 2020
Published for Opposition
Tuesday, April 21, 2020
Abandoned Date
Monday, January 17, 2022
5 Pharmaceutical preparations and therapeutic vaccines for the treatment of cancer and immune system related diseases
42 Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology, immunology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, immunology and pharmaceuticals
Jan 18, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 17, 2022
Abandonment - No Use Statement Filed
Jun 17, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 15, 2021
Extension 2 Granted
Jun 15, 2021
Extension 2 Filed
Jun 15, 2021
Teas Extension Received
Dec 15, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 11, 2020
Extension 1 Granted
Dec 11, 2020
Extension 1 Filed
Dec 11, 2020
Teas Extension Received
Jun 16, 2020
Noa E-Mailed - Sou Required From Applicant
Apr 21, 2020
Official Gazette Publication Confirmation E-Mailed
Apr 21, 2020
Published For Opposition
Apr 1, 2020
Notification Of Notice Of Publication E-Mailed
Mar 18, 2020
Assigned To Lie
Mar 11, 2020
Approved For Pub - Principal Register
Mar 10, 2020
Teas/Email Correspondence Entered
Mar 9, 2020
Correspondence Received In Law Office
Mar 9, 2020
Teas Response To Office Action Received
Mar 9, 2020
Notification Of Examiner's Amendment/Priority Action E-Mailed
Mar 9, 2020
Examiner's Amendment/Priority Action E-Mailed
Mar 9, 2020
Combined Examiner's Amendment/Priority Action Automatic Entry
Mar 9, 2020
Examiners Amendment And/Or Priority Action - Completed
Mar 6, 2020
Assigned To Examiner
Feb 13, 2020
New Application Office Supplied Data Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24